Relapsed pediatric ALL
Clinical trials for Relapsed pediatric ALL explained in plain language.
Never miss a new study
Get alerted when new Relapsed pediatric ALL trials appear
Sign up with your email to follow new studies for Relapsed pediatric ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells aim to wipe out stubborn leukemia
Cure Recruiting nowResearchers are testing a CAR-T therapy called pCAR-19B in people with CD19-positive B-cell acute lymphoblastic leukemia that has relapsed or stopped responding to standard treatment. Participants receive an intravenous infusion of their own immune cells, which have been engineer…
Matched conditions: RELAPSED PEDIATRIC ALL
Phase 2 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
New hope for kids with tough leukemia: transplant plus CAR t cells
Disease control Recruiting nowThis study tests a new way to do a stem cell transplant for children with a hard-to-treat type of leukemia (ALL). Doctors will use special immune cells (CAR T cells) after the transplant to try to kill any remaining cancer cells. The goal is to see if this approach is safe and wo…
Matched conditions: RELAPSED PEDIATRIC ALL
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Experimental CAR T-Cell therapy targets tough blood cancers
Disease control Recruiting nowThis study tests a personalized cell therapy called CAR T-cells for people with relapsed or hard-to-treat lymphoma or acute lymphoblastic leukemia (ALL). The therapy involves collecting a patient's own immune cells, modifying them to recognize and attack cancer cells, and infusin…
Matched conditions: RELAPSED PEDIATRIC ALL
Phase 1/2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC